BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20718839)

  • 1. Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.
    Moran BJ
    Colorectal Dis; 2010 Sep; 12(9):872-3. PubMed ID: 20718839
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
    Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
    Sugarbaker PH
    Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].
    Dartigues P
    Ann Pathol; 2015 Aug; 35(4):311-20. PubMed ID: 26210688
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival of patients with pseudomyxoma peritonei treated by serial debulking.
    Järvinen P; Järvinen HJ; Lepistö A
    Colorectal Dis; 2010 Sep; 12(9):868-72. PubMed ID: 19519686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Iavazzo C; Spiliotis J
    Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
    [No Abstract]   [Full Text] [Related]  

  • 9. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
    Hosch WP; Rudi J; Stremmel W
    Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal pseudomyxoma].
    Zoetmulder FA; Bakker XR
    Ned Tijdschr Geneeskd; 1997 Aug; 141(31):1542-3. PubMed ID: 9543746
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Saxena A; Yan TD; Chua TC; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomyxoma peritonei of appendiceal origin--a report of seven cases and a review of published reports.
    Lang H; Jähne J; Flemming P; Meyer HJ; Pichlmayr R
    Eur J Surg; 1995 May; 161(5):355-60. PubMed ID: 7662781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?
    Huang Y; Alzahrani NA; Liauw W; Traiki TB; Morris DL
    Ann Surg Oncol; 2017 Jan; 24(1):176-183. PubMed ID: 27718032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin.
    Järvinen P; Ristimäki A; Kantonen J; Aronen M; Huuhtanen R; Järvinen H; Lepistö A
    Int J Colorectal Dis; 2014 Aug; 29(8):999-1007. PubMed ID: 24965858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
    Mahteme H; Sugarbaker PH
    Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin.
    Youssef H; Newman C; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Dis Colon Rectum; 2011 Mar; 54(3):293-9. PubMed ID: 21304299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.